BHC:CC News and Press, Bausch Health Companies Inc. From 05/23/24

A look at the top 10 most actives in Canada Desjardins American Equity Index ETF (DMEU) rose 0.0% to $20.84 on volume of 15,228,481 shares Desjardins International Equity Index ETF (DMEI) rose 0.4% to $20.78 on volume of 4,983,702 shares Western Atlas Resources (WA) rose 0.0% to $0.015 on...

2024-05-22 16:31:48 ET Summary Bausch + Lomb, a spin-off from Bausch Health, has shown solid performance with revenues of $4.1bn in 2023 and a narrowing net loss of $(260m). The company's Q1 2024 report shows growth in all segments, including Vision Care, Surgical, and Pharmaceuti...

A look at the top 10 most actives in Canada Enbridge Inc. (ENB) fell 0.2% to $50.12 on volume of 18,576,382 shares Rusoro Mining Ltd. (RML) rose 5.0% to $1.47 on volume of 17,326,128 shares ATEX Resources Inc. (ATX) rose 1.4% to $1.42 on volume of 14,202,550 shares Manulife Financial Co...

A look at the top 10 most actives in Canada Rua Gold Inc. (RUA) rose 12.2% to $0.23 on volume of 2,091,479 shares Lion Copper and Gold Corp. (LEO) rose 0.0% to $0.085 on volume of 1,763,000 shares Hudbay Minerals Inc. (HBM) fell 5.9% to $13.31 on volume of 1,708,922 shares IAMGOLD Corpo...

LAVAL, QC / ACCESSWIRE / May 17, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, today announced that they will be presenting data from its Phase 2 trial evaluating Amiselimod as treatment for active ulcerative colitis (UC). ...

LAVAL, QC / ACCESSWIRE / May 15, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the results of its 2024 annual meeting of shareholders. Annual Meeting Results The 10 directors nominated at the Company's 2024 annual meeting of shareholders held on May 14, 2024, were e...

2024-05-14 16:51:58 ET More on Bausch Health Companies Why Bausch Health Stock Plunged After Posting First Quarter 2024 Results Bausch Health Companies (BHC) Q1 2024 Earnings Call Transcript Bausch Health Companies Inc. 2024 Q1 - Results - Earnings Call Presentation ...

LAVAL, QC / ACCESSWIRE / May 14, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology business Salix Pharmaceuticals, today announced certain updates related to its litigation with Norwich Pharmaceuticals, Inc. With respect to the April 11, 2024, decision of the US C...

Xifaxan is the first and only FDA approved medication for the reduction in risk of OHE recurrence in adults Overt Hepatic Encephalopathy is caused by cirrhosis of the liver As complications from chronic liver disease increase, recognizing OHE is critical so that patients can work with t...

2024-05-07 09:15:00 ET Summary Bausch Health Companies stock experienced a significant drop after posting its first-quarter results, missing expectations by 13 cents. The company's debt maturity profile raises concerns for investors, with a large amount of debt maturing in 2025 an...